These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 17951401)
21. Epithelial-mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis. Lou Y; Preobrazhenska O; auf dem Keller U; Sutcliffe M; Barclay L; McDonald PC; Roskelley C; Overall CM; Dedhar S Dev Dyn; 2008 Oct; 237(10):2755-68. PubMed ID: 18773493 [TBL] [Abstract][Full Text] [Related]
22. Matrix metalloproteinase-1 is a crucial bone metastasis factor in a human breast cancer-derived highly invasive cell line. Okuyama N; Matsumine A; Kosugi R; Wakabayashi H; Uchida A Oncol Rep; 2008 Dec; 20(6):1497-504. PubMed ID: 19020733 [TBL] [Abstract][Full Text] [Related]
23. Enhanced expression of LKB1 in breast cancer cells attenuates angiogenesis, invasion, and metastatic potential. Zhuang ZG; Di GH; Shen ZZ; Ding J; Shao ZM Mol Cancer Res; 2006 Nov; 4(11):843-9. PubMed ID: 17114342 [TBL] [Abstract][Full Text] [Related]
24. RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes. Armstrong AP; Miller RE; Jones JC; Zhang J; Keller ET; Dougall WC Prostate; 2008 Jan; 68(1):92-104. PubMed ID: 18008334 [TBL] [Abstract][Full Text] [Related]
25. Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model. Moreau JE; Anderson K; Mauney JR; Nguyen T; Kaplan DL; Rosenblatt M Cancer Res; 2007 Nov; 67(21):10304-8. PubMed ID: 17974972 [TBL] [Abstract][Full Text] [Related]
26. COX-2 involvement in breast cancer metastasis to bone. Singh B; Berry JA; Shoher A; Ayers GD; Wei C; Lucci A Oncogene; 2007 May; 26(26):3789-96. PubMed ID: 17213821 [TBL] [Abstract][Full Text] [Related]
27. COX-2 induces IL-11 production in human breast cancer cells. Singh B; Berry JA; Shoher A; Lucci A J Surg Res; 2006 Apr; 131(2):267-75. PubMed ID: 16457848 [TBL] [Abstract][Full Text] [Related]
28. A mouse model of human breast cancer metastasis to human bone. Kuperwasser C; Dessain S; Bierbaum BE; Garnet D; Sperandio K; Gauvin GP; Naber SP; Weinberg RA; Rosenblatt M Cancer Res; 2005 Jul; 65(14):6130-8. PubMed ID: 16024614 [TBL] [Abstract][Full Text] [Related]
29. Expression of bone matrix proteins in human breast cancer: potential roles in microcalcification formation and in the genesis of bone metastases. Bellahcène A; Castronovo V Bull Cancer; 1997 Jan; 84(1):17-24. PubMed ID: 9180854 [TBL] [Abstract][Full Text] [Related]
30. Characterization of the glycosylation profile of the human breast cancer cell line, MDA-231, and a bone colonizing variant. Carcel-Trullols J; Stanley JS; Saha R; Shaaf S; Bendre MS; Monzavi-Karbassi B; Suva LJ; Kieber-Emmons T Int J Oncol; 2006 May; 28(5):1173-83. PubMed ID: 16596233 [TBL] [Abstract][Full Text] [Related]
31. Silencing of cyclooxygenase-2 inhibits metastasis and delays tumor onset of poorly differentiated metastatic breast cancer cells. Stasinopoulos I; O'Brien DR; Wildes F; Glunde K; Bhujwalla ZM Mol Cancer Res; 2007 May; 5(5):435-42. PubMed ID: 17510310 [TBL] [Abstract][Full Text] [Related]
32. Involvement of IL-8 in COX-2-mediated bone metastases from breast cancer. Singh B; Berry JA; Vincent LE; Lucci A J Surg Res; 2006 Jul; 134(1):44-51. PubMed ID: 16678856 [TBL] [Abstract][Full Text] [Related]
33. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma. Guo B; Zhang Y; Luo G; Li L; Zhang J Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240 [TBL] [Abstract][Full Text] [Related]
34. Transcriptome analysis reveals an osteoblast-like phenotype for human osteotropic breast cancer cells. Bellahcène A; Bachelier R; Detry C; Lidereau R; Clézardin P; Castronovo V Breast Cancer Res Treat; 2007 Jan; 101(2):135-48. PubMed ID: 17028989 [TBL] [Abstract][Full Text] [Related]
35. A novel lung cancer signature mediates metastatic bone colonization by a dual mechanism. Vicent S; Luis-Ravelo D; Antón I; García-Tuñón I; Borrás-Cuesta F; Dotor J; De Las Rivas J; Lecanda F Cancer Res; 2008 Apr; 68(7):2275-85. PubMed ID: 18381434 [TBL] [Abstract][Full Text] [Related]
36. Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons. Wu MH; Hong TM; Cheng HW; Pan SH; Liang YR; Hong HC; Chiang WF; Wong TY; Shieh DB; Shiau AL; Jin YT; Chen YL Mol Cancer Res; 2009 Mar; 7(3):311-8. PubMed ID: 19276182 [TBL] [Abstract][Full Text] [Related]
37. Decorin suppresses bone metastasis in a breast cancer cell line. Araki K; Wakabayashi H; Shintani K; Morikawa J; Matsumine A; Kusuzaki K; Sudo A; Uchida A Oncology; 2009; 77(2):92-9. PubMed ID: 19590249 [TBL] [Abstract][Full Text] [Related]
38. Expression of estrogen receptor beta increases integrin alpha1 and integrin beta1 levels and enhances adhesion of breast cancer cells. Lindberg K; Ström A; Lock JG; Gustafsson JA; Haldosén LA; Helguero LA J Cell Physiol; 2010 Jan; 222(1):156-67. PubMed ID: 19780039 [TBL] [Abstract][Full Text] [Related]
39. TIP30/CC3 expression in breast carcinoma: relation to metastasis, clinicopathologic parameters, and P53 expression. Zhao J; Ni H; Ma Y; Dong L; Dai J; Zhao F; Yan X; Lu B; Xu H; Guo Y Hum Pathol; 2007 Feb; 38(2):293-8. PubMed ID: 17097132 [TBL] [Abstract][Full Text] [Related]
40. Metastatic breast cancer induces an osteoblast inflammatory response. Kinder M; Chislock E; Bussard KM; Shuman L; Mastro AM Exp Cell Res; 2008 Jan; 314(1):173-83. PubMed ID: 17976581 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]